Stocks in Play: Medicenna Therapeutics Corp. - InvestingChannel

Stocks in Play: Medicenna Therapeutics Corp.

Thursday, September 28, 2023

10:18 AM EST – Medicenna Therapeutics Corp. : Will present preclinical results featuring its MDNA223 BiSKIT candidate at the 2023 AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy to be held from October 1 – 4, in Toronto. Medicenna Therapeutics Corp. (T.MDNA) shares were unchanged at 0.38.

Stocks in Play: Medicenna Therapeutics Corp., Thu, 28 Sep 2023 10:27:06 EST

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire